| Literature DB >> 33892692 |
Simone Battista1,2, Stefano Salvioli1, Serena Millotti1, Marco Testa1, Andrea Dell'Isola3.
Abstract
INTRODUCTION: Implementation of clinical practice guidelines (CPGs) to manage musculoskeletal conditions among physiotherapists appears suboptimal. Osteoarthritis is one of the most disabling conditions worldwide and several studies showed a lack of knowledge of and adherence to osteoarthritis CPGs in physiotherapists' clinical practice. However, those studies are not conclusive, as they examine the knowledge of and adherence to CPGs only in isolation, or only by focussing on a single treatment. Thus, analysis of the knowledge of and adherence to CPGs in the same sample would allow for a better understanding of the evidence-to-practice gap, which, if unaddressed, can lead to suboptimal care for these patients. This study aims at assessing Italian physiotherapists' evidence-to-practice gap in osteoarthritis CPGs.Entities:
Keywords: Clinical governance; Education, public health professional; Osteoarthritis; Osteoarthritis, hip; Osteoarthritis, knee; Physical therapists; Physical therapy specialty; Practice guidelines as topic
Mesh:
Year: 2021 PMID: 33892692 PMCID: PMC8067645 DOI: 10.1186/s12891-021-04250-4
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Section 1: Statements and synoptic review of Clinical Practice Guidelines
| Statements | Clinical Practice Guidelines |
|---|---|
| 1) Exercise can be effective on all patients, regardless of the pain severity. | NICE (1.2.5–1.4.1) [ OARSI (Tables |
| 2) In an advanced stage of the disease, exercise can damage the joint ( | NICE (1.2.5–1.4.1) [ OARSI (Tables |
| 3) The rehabilitation programme must always include a part of education on the pathophysiology of osteoarthritis and self-management strategies. | NICE (1.3.1–1.3.2–1.3.3) [ |
| 4) The rehabilitation programme should always include a part of manual treatment ( | NICE (1.4.2) [ |
| 5) Exercise should only be undertaken after prescribing drug treatment to control pain ( | NICE (1.2.5–1.4.1) [ OARSI (Tables |
| 6) The use of topical anti-inflammatory drugs is effective for pain relief for knee osteoarthritis. | NICE (1.5.3) [ |
| 7) Radiographic findings are needed to express a functional diagnosis of osteoarthritis ( | NICE (1.1.1) [ |
| 8) Radiographic findings are needed to plan the physiotherapy treatment ( | NICE (1.1.1) [ |
| 9) Physical activity should be avoided because it can damage the joint ( | NICE (1.2.5–1.4.1) [ OARSI (Tables |
| 10) The use of topical anti-inflammatory drugs is effective for pain relief for hip osteoarthritis. | NICE (−); EULAR (−); OARSI (−) |
| 11) In case of severe joint degeneration, it is necessary to recommend rest from physical activity ( | NICE (1.2.5–1.4.1) [ OARSI (Tables |
| 12) In cases of severe pain (VAS ≥ 6/10), arthroplasty surgery should be preferred to rehabilitation ( | NICE (1.6) [ |
| 13) The use of TENS should be considered. | NICE (1.4.4) [ |
| 14) The use of physical therapies such as lasers, TECAR and ultrasound therapy should be considered ( | NICE (1.4.4) [ |
| 15) In addition to the rehabilitation treatment, it is useful to recommend physical activity (for example, yoga, swimming, Nordic walking). | NICE (1.2.5–1.3.2–1.4.1) [ |
| 16) It is important to recommend weight loss to overweight or obese patients. | NICE (1.2.5–1.4.3) [ |
| 17) Age > 45, pain and absence of joint stiffness (or < 30 min) in the morning are sufficient to diagnose osteoarthritis. | NICE (1.1.1) [ |
| 18) The use of comfortable footwear, braces or aids should be considered. | NICE (1.3.2–1.4.7–1.4.8–1.4.9) [ |
| 19) It is advisable to refer the patient for arthroscopy surgery to reduce symptoms and start/continue treatment ( | NICE (1.4.10) [ |
| 20) It is necessary to assess the impact of osteoarthritis on function, quality of life and disability. | NICE (1.2.1) [ |
| 21) At least 10–12 sessions are needed to ensure proper treatment for osteoarthritis. | NICE (1.4.1) [ |
| 22) In the treatment for osteoarthritis, the patient’s adherence to the treatment must be motivated. | NICE (1.3.2–1.4.1–1.7.1) [ |
| 23) Joint hyaluronic acid and/or corticosteroid infiltrations should be considered. | NICE (1.5.12–1.5.13) [ |
| 24) The supplements of chondroitin and glucosamine should be considered ( | NICE (1.4.5) [ |
Legend: (n), CPGs paragraph into which the statements were originally reported; (−), the CPGs did not adopt a position on that statement; [n], CPGs reference
Section 2: Clinical vignette proposed treatments
| Clinical Scenario: | ||
|---|---|---|
| Core Treatment | Partially Core Treatment | Non-Core Treatment |
• Evaluation and planning of the rehabilitation treatment; • Weight loss advice. | • Referral to the physician for drug therapy. | • Referral to the physician for arthroscopic surgery (joint debridement); • Referral to the physician for prosthetic intervention. |
| Core Treatment | ||
• Assessment of the quantity and quality of pain; • Assessment of the function; • Assessment of disability and participation. | ||
| Core Treatment | Partially Core Treatment | Non-Core Treatment |
• Specific exercise on the joint (muscle strengthening); • Generic exercise (aerobic exercise or generic physical activity); • Education on the pathophysiology of osteoarthritis. | • Manual therapy (mobilisation and/or massage); • TENS; • Load reduction devices (braces, insoles or walking aids); Hyaluronic acid and corticosteroid injections. | • Activity rest (reduce the load on the joint); • Other physical therapies (Laser, Ultrasound etc.); • Supplement integration: glucosamine and chondroitin |
For how many sessions would you treat this patient? • For less than 5 sessions; • Between 5 and 10 sessions; • For more than 10 sessions. | ||
Participants’ demographic characteristics
| Demographic Characteristics | |
|---|---|
| 35.77 (13.3) | |
| 387 (47); 435 (53) | |
| Less than 1 year | 87 (11) |
| From 1 to 5 years | 319 (39) |
| From 6 to 10 years | 149 (18) |
| More than 10 years | 267 (32) |
| Bachelor of Science (BSc)/Equivalent title | 282 (34) |
| Post-Graduate I Level Degree* | 382 (47) |
| Master of Science (MSc)/Post-Graduate II Level Degree† | 122 (15) |
| Doctor of Philosophy (PhD) | 36 (4) |
| Yes | 465 (57) |
| No | 357 (43) |
Legend: N, number; %, percentage; *Academic degree that can be gained after BSc (Italian education system); † Academic degree that can be gained after MSc (Italian education system)
Fig. 1Participants’ Flowchart
Fig. 2Level of agreement with Osteoarthritis (OA) Clinical Practice Guidelines Statements. * Statement originally reversed in the questionnaire. † The red line represents the consensus threshold set at 70%. ‡ The statements are reported in a shortened version, see Table 1 for reference
Participants’ profile by level of adherence for the Clinical Vignette
| ‘Delivering’ (N = 202) | ‘Partially Delivering’ (N = 181) | ‘Non-Delivering’ (N = 439) | |
|---|---|---|---|
| 31.2 (10.9) | 37.4 (13.7) | 37.2 (13.7) | |
| Female | 81 (40) | 86 (48) | 220 (50) |
| Male | 121 (60) | 95 (52) | 219 (50) |
| Less than 1 year | 30 (15) | 18 (10) | 39 (9) |
| From 1 to 5 years | 100 (50) | 71 (39) | 148 (34) |
| From 6 to 10 years | 40 (20) | 28 (16) | 81 (18) |
| More than 10 years | 32 (15) | 64 (35) | 171 (39) |
| Bachelor of Science (BSc)/Equivalent level | 57 (28) | 64 (35) | 161 (37) |
| I Level Master Degree* | 115 (57) | 79 (44) | 188 (43) |
| Master of Science (MSc)/II Level Master† | 23 (11) | 32 (18) | 67 (15) |
| Doctor of Philosophy (PhD) | 7 (4) | 6 (3) | 23 (5) |
| Yes | 124 (61) | 114 (63) | 240 (55) |
| No | 78 (39) | 67 (37) | 199 (45) |
Legend: N, number; %, percentage; *Academic degree that can be gained after BSc (Italian education system); † Academic degree that can be gained after MSc (Italian education system)
Frequencies of answers to Clinical Vignette by level of adherence with Clinical Practice Guidelines
| Question | All ( | ‘Delivering’ (N = 202; 25%) | ‘Partial Delivering’ (N = 181; 22%) | ‘Non-Delivering’ (N = 439; 53%) | ||||
|---|---|---|---|---|---|---|---|---|
| YES | NO | YES | NO | YES | NO | YES | NO | |
| 1) Physiotherapy treatment | 794 (97) | 28 (3) | 202 (100) | 0 (0) | 181 (100) | 0 (0) | 411 (94) | 28 (6) |
| 2) Referral pharmacological | 159 (19) | 663 (81) | 40 (20) | 162 (80) | 15 (8) | 166 (92) | 104 (24) | 335 (76) |
| 3) Referral for debridment | 15 (2) | 807 (98) | 0 (0) | 202 (100) | 0 (0) | 181 (100) | 15 (3) | 424 (97) |
| 4) Referral for surgery | 26 (3) | 796 (97) | 0 (0) | 202 (100) | 0 (0) | 181 (100) | 26 (6) | 413 (94) |
| 5) Weight Loss | 645 (79) | 177 (21) | 202 (100) | 0 (0) | 90 (50) | 91 (50) | 353 (80) | 86 (20) |
| 1) Pain | 727 (88) | 95 (12) | 202 (100) | 0 (0) | 138 (76) | 43 (24) | 387 (88) | 52 (12) |
| 2) Functionality | 756 (92) | 66 (8) | 202 (100) | 0 (0) | 164 (91) | 17 (9) | 390 (89) | 49 (11) |
| 3) Disability and Partecipation | 722 (88) | 100 (12) | 202 (100) | 0 (0) | 149 (82) | 32 (18) | 371 (85) | 68 (15) |
| 1) Load reduction (rest) | 244 (30) | 578 (70) | 0 (0) | 202 (100) | 0 (0) | 181 (100) | 244 (56) | 195 (44) |
| 2) Manual therapy | 612 (75) | 210 (25) | 145 (72) | 57 (28) | 135 (75) | 46 (25) | 332 (76) | 107 (24) |
| 3) Muscles strengthening | 702 (85) | 120 (15) | 202 (100) | 0 (0) | 143 (79) | 38 (21) | 357 (81) | 82 (19) |
| 4) Generic exercise (e.g. aerobic exercise or generic physical activity) | 525 (64) | 297 (36.) | 202 (100) | 0 (0) | 92 (51) | 89 (49) | 231 (53) | 208 (47) |
| 5) Education on the pathophysiology of osteoarthritis | 698 (85) | 124 (15) | 202 (100) | 0 (0) | 142 (78) | 39 (21) | 354 (81) | 85 (19) |
| 6) TENS | 111 (14) | 711 (86) | 25 (12) | 177 (88) | 27 (15) | 154 (85) | 59 (13) | 380 (87) |
| 7) Other Physical Therapies (e.g. ultrasound and laser) | 137 (17) | 685 (83) | 0 (0) | 202 (100) | 0 (0) | 181 (100) | 137 (31) | 302 (69) |
| 8) Load reduction devices (e.g. braces, insoles or walking aids). | 185 (23) | 637 (77) | 30 (15) | 172 (85) | 34 (19) | 147 (82) | 121 (28) | 318 (72) |
| 9) Hyaluronic acid and corticosteroids | 111 (14) | 711 (86) | 7 (4) | 195 (96) | 19 (11) | 162 (89) | 85 (19) | 354 (81) |
| 10) Treatment: Supplements | 279 (34) | 543 (66) | 0 (0) | 202 (100) | 0 (0) | 181 (100) | 77 (18) | 362 (82) |
| Less than 5 sessions | 71 (9) | 0 (0) | 0 (0) | 71 (17) | Less than 5 sessions | 71 (9) | 0 (0) | 0 (0) |
| Between 5 and 10 sessions | 465 (58) | 138 (68) | 121 (67) | 206 (50) | Between 5 and 10 sessions | 465 (58) | 138 (68) | 121 (67) |
| More than 10 sessions | 258 (33) | 64 (32) | 60 (33) | 134 (33) | More than 10 sessions | 258 (33) | 64 (32) | 60 (33) |
Legend: N, number; %, percentage; *Percentage calculated on N = 794; N = 28 could not access to this section as they didn’t check the “Management section: 1) Physiotherapy treatment” option